← All organizations

Highest phase reached
Phase 3
First clinical trial
Sep 1, 2012Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 3, 2011
albumin (Human)— NDA Secondary Org
- Jul 1, 2011
Kedrion SpA— Founded
Drugs by trial phase (6 distinct, 11 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (2)
Recent trials (15)
- NCT04586062Lead sponsorN/A—
- NCT06963216Lead sponsorPhase 3Dec 31, 2025
- NCT06752356Lead sponsorPhase 3Nov 30, 2025
- NCT06752356OfficialPhase 3Nov 30, 2025
- NCT07059000OfficialPhase 3Aug 13, 2025
- NCT07059000Lead sponsorPhase 3Aug 13, 2025
- NCT04944979Lead sponsorPhase 3Mar 31, 2021
- NCT04345679CollaboratorEarly Phase 1Apr 14, 2020
- NCT03961009Overall official - principal investigatorPhase 3Apr 30, 2019
- NCT03961009Lead sponsorPhase 3Apr 30, 2019
- NCT02912845CollaboratorPhase 3Jan 1, 2017
- NCT01581593Lead sponsorPhase 3Nov 1, 2012
- NCT01581593Study directorPhase 3Nov 1, 2012
- NCT01531803Lead sponsorPhase 2/Phase 3Sep 1, 2012
- NCT01554956Lead sponsorPhase 2/Phase 3Sep 1, 2012
Details
- Founded
- Fort Lee, NJ, US Jul 1, 2011
- Last known activity
- Dec 31, 2025